Executives
-
Guindo ChirfiChief Marketing Officer -
Smart DaltonSVP Fin. - Global Controller
-
Deluca Richard R.EVP&Pres, Merck Animal Heallth
-
Oosthuizen Johannes JacobusPresident, U.S. Market
-
Larson Betty DEVP, Chief HR Officer
-
Downing Cristal NChief Comm. & Public Afrs Ofcr
-
Zachary JenniferEVP, General Counsel
-
Li Dean YExecutive VP & President, MRL
-
Davis Robert MChairman, CEO & President
-
Chattopadhyay SanatExe V-P & Pres. MMD
-
Williams David MichaelEVP,Chief Info&Digital Officer
-
Litchfield CarolineEVP & CFO
-
Mizell StevenEVP, Chief HR Officer
?
Zachary Jennifer
EVP, General Counsel
Merck & Co., Inc.
US, Kenilworth [HQ]
CIK
1737231
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
5,913,976
Price per Share :
$100.03
Equivalence :
$591,575,019.28
Transaction History
-
A5,913,976 Shares After TransactionValue : $706,306,153.68$2,782,480.14Transaction Date : 01/22/24
-
Footnotes
-
-
Footnotes:#1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023.#2 Holdings include shares acquired in dividend reinvestment transactions.
-
M7,855,676 Shares After TransactionValue : $684,229,379.60$1,691,220.70Transaction Date : 02/02/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.8650 to $127.3000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.#2 Holdings include shares acquired in dividend reinvestment transactions.
-
S2,905,776 Shares After TransactionValue : $368,946,378.72Sold $6,284,888.03Transaction Date : 02/02/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.8650 to $127.3000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.#2 Holdings include shares acquired in dividend reinvestment transactions.